← Leaderboards
Qin Yan
Yale University
$5,511,459
Attributed
$5,511,459
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $758.9K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,511,459 · 5
By mechanism
P50$2,814,301 · 2
R01$1,900,454 · 1
R21$796,704 · 2
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Harriet M Kluger$18,066,555
- Gary V. Desir$8,576,842
- Martin Ignacio Garcia-Castro$7,456,537
- Walther H Mothes$28,899,611
- Kathryn Miller-Jensen$6,168,144
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorTranslatingInnovationDrug TargetingEpigenetic ProcessMissionClinicCancer TherapyDiagnosisTherapeutic TargetPublic HealthValidationHistone DemethylaseBaseImmunotherapyKdm5b GeneExperimental StudyAnti-Tumor Immune ResponseTumor ImmunityClinical TrialsPre-ClinicalImmune Checkpoint BlockadeImmunologicsDown-Regulation
Grant awards (17)
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma$435,370
P50 · FY2025 · CA · contact PI
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma$414,525
P50 · FY2024 · CA · contact PI
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma$383,417
P50 · FY2023 · CA · contact PI
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER$375,493
R01 · FY2023 · CA · contact PI
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER$375,493
R01 · FY2022 · CA · contact PI
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity$294,427
P50 · FY2022 · CA · contact PI
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER$383,156
R01 · FY2021 · CA · contact PI
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity$315,555
P50 · FY2021 · CA · contact PI
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER$383,156
R01 · FY2020 · CA · contact PI
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity$320,464
P50 · FY2020 · CA · contact PI
TARGETING HISTONE DEMETHYLASE KDM5B IN BREAST CANCER$383,156
R01 · FY2019 · CA · contact PI
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity$315,543
P50 · FY2019 · CA · contact PI
Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity$335,000
P50 · FY2018 · CA · contact PI
IDENTIFYING EPIGENETIC CHANGES CRITICAL FOR TRASTUZUMAB RESISTANCE$217,283
R21 · FY2016 · CA · contact PI
TARGETING EPIGENETIC REGULATORS TO SUPPRESS BREAST CANCER METASTASIS$217,283
R21 · FY2016 · CA · contact PI
TARGETING EPIGENETIC REGULATORS TO SUPPRESS BREAST CANCER METASTASIS$181,069
R21 · FY2015 · CA · contact PI
IDENTIFYING EPIGENETIC CHANGES CRITICAL FOR TRASTUZUMAB RESISTANCE$181,069
R21 · FY2015 · CA · contact PI